Private Equity Player OrbiMed Registers for $300 Million Fund

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Private equity shop OrbiMed Advisors, which invests in medical device and other healthcare companies, registers to raise a $300 million fund. Private equity player OrbiMed Advisors, which invests in the life science space, registered to raise a $300 million fund to invest in healthcare companies in Asia, according to an SEC filing. OrbiMed's Shanghai- and Mumbai-based Asia PE fund focuses on "opportunities in China and India across all sectors of healthcare, including healthcare services," according to its website.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC